REFLECTING ON 2025
As we reflect on 2025, we are filled with gratitude for the global community that defines the International Association for the Study of Lung Cancer. Our members, from clinicians and researchers to advocates, nurses, patients, and more, are the heart and soul of this organization. We see our role as stewards of your success because when our members succeed, IASLC succeeds. This annual report is both a celebration of what we have achieved together and a reflection of our ongoing commitment to listen, respond, and deliver meaningful progress you can see and feel.
This report will outline yet another productive year from IASLC, one which we are very proud of. But before we dig into the details of 2025, we want to take a moment to reflect on our most impactful accomplishments. Our commitment to equity, inclusion, and future leadership took meaningful shape this year; in particular, voting to reduce board terms from four years to three years gives members more leadership opportunities. You also elected the most diverse board in IASLC history in terms of disciplines and geography while maintaining gender quotas, and we selected new committee members across our 14 committees. In addition, we established the Women in Thoracic Oncology Taskforce to support women health professionals across regions, disciplines, and career stages through leadership development, mentorship, networking, and advocacy. Finally, we launched an AI Taskforce to explore how artificial intelligence can be used responsibly and effectively to advance thoracic oncology, from research and data analysis to clinical applications. Both of these task forces present members with additional engagement and leadership opportunities.
We took your advice to increase networking and interactive sessions at our conferences and continue to explore novel strategies. In addition, the launch of Thoracic Circle, our interactive communication platform, provides members with virtual networking and collaboration tools year long. It’s a critical tool for members looking to connect outside of conferences.
We launched our first mid-career grant mechanism, awarded our first team science grant, and are continuing to enhance our educational hub, Lung Cancer 360.
2025 marked an important moment for lung cancer on the global stage. IASLC hosted its inaugural Pan Africa Conference on Lung Cancer in Accra, Ghana, and the board has approved the continuation of this conference every two years. IASLC is focused on ensuring lung cancer remains an international priority. Through the work of our Global Policy & Partnerships Committee, we launched the IASLC Global Lung Cancer Policy Report, helping to provide a framework to support advocacy, policy change, and government engagement worldwide. In partnership with The Lancet, IASLC launched the IASLC–Lancet Commission on Lung Cancer to reframe lung cancer as a global health challenge, not just a clinical one. The Commission will bring together experts from around the world to address inequities, promote prevention and early detection, expand access to diagnostics and therapies, and strengthen collaboration among governments, health systems, and civil society. This work underscores the power of partnerships to influence policymakers and drive change on a global scale.
None of this progress would be possible without the dedication of our members and volunteers, who generously give their time and expertise despite already demanding professional lives. You are not only contributors to IASLC; you are its voice, its strength, and its future. As we look ahead, we remain committed to helping you succeed, expanding our global reach, and advancing collaborative science, education, and multidisciplinary care. Together, we are marching forward toward a world where thoracic cancers are better understood, better treated, and ultimately conquered.
